Coal tar with salicylic acid
Brand names: Coco-Scalp
A topical preparation combining coal tar with salicylic acid, used for chronic scaling skin and scalp conditions, particularly plaque psoriasis and seborrhoeic dermatitis, where thick adherent scale is a feature.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Coal tar provides anti-inflammatory, antiscaling and antipruritic effects while salicylic acid acts as a keratolytic, softening and removing scale and improving penetration of the coal tar.
Prescribing in practice
- Coal tar increases sensitivity to ultraviolet light, so treated areas should be protected from strong sunlight and care taken if phototherapy is also used.
- Avoid application to broken, infected or acutely inflamed skin, and keep away from the eyes, as both components can irritate.
- Salicylic acid is absorbed through the skin, so avoid extensive or prolonged use, particularly in children, to reduce the risk of salicylate toxicity.
Monitoring
No routine laboratory monitoring is required; review the treated area for irritation and clinical response.
Counselling the patient
- Apply as directed, avoid the eyes and surrounding healthy skin, and wash your hands afterwards.
- Expect a tar odour and possible staining of fabrics and light hair.
- Protect treated skin from strong sunlight and stop if irritation develops.
Evidence & guidelines
Coal tar with salicylic acid is an established keratolytic-antiscaling option for scaling psoriasis and is used within NICE-supported stepped topical therapy.
Reference: Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- PASI — Psoriasis Area and Severity Index · Diagnosis
- DLQI — Dermatology Life Quality Index · Diagnosis
- PASI Score (Psoriasis Area and Severity Index) · Psoriasis
- DLQI (Dermatology Life Quality Index) · Quality of Life
- Tumor Lysis Syndrome Risk (Cairo-Bishop) · Oncological Emergency
- FAST Exam Protocol — Focused Assessment with Sonography in Trauma · Trauma
- Suspicious Pigmented Lesion — Melanoma Pathway · NICE NG14 2015 / BAD
- Cellulitis and Erysipelas · NICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Urticaria and Angioedema · BSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD